期刊文献+

首发和复发双相情感障碍患者血浆非酶类抗氧化剂的比较研究 被引量:1

Plasma non-enzymatic antioxidants in first onset and recurrent bipolar disorder patients:a comparative study
原文传递
导出
摘要 目的比较首发和复发双相情感障碍患者血浆非酶类抗氧化剂的差异。方法对30例首发双相情感障碍患者、49例复发患者、42例正常对照者进行血浆非酶类抗氧化剂(清蛋白、尿酸、总胆红素)的检测。结果首发和复发双相情感障碍患者血浆非酶类抗氧化剂的差异无统计学意义;首发双相情感障碍组胆红素比对照组低,复发双相情感障碍组清蛋白、胆红素比对照级低,差异有统计学意义。复发双相情感障碍患者血浆中3种非酶类抗氧化剂和病程及情感障碍发作次数没有相关性。结论首发和复发双相情感障碍患者均存在抗氧化系统的失调并进一步导致氧化应激,这种氧化应激可能在双相情感障碍的发病初期就存在,和药物治疗、病程及情感障碍发作次数无关。 Objective To explore the difference of plasma non-enzymatic antioxidants between first onset and recurrent bipolar disorder(BD)patients. Methods A total of 30 first onset BD patients, 49 recurrent BD patients and 42 healthy subjects (as the controls) were investigated. The plasma non-enzymatic antioxidants (albumin, uric acid and total bilirubin) were examined in their plasma samples. Results The non-enzymatic antioxidants levels in the first onset and recurrent BD groups were not significantly different. The total bilirubin level of the first onset BP group was significantly lower than that of the control group, and the albumin and total bilirubin in the recurrent BP group were significantly lower than those of the control group. The levels of 3 types of non-enzymatic antioxidants in the recurrent BD group were not correlated with the disease duration and the number of recurrent episodes. Conclusions Both first onset and recurrent BD patients have antioxidant defense system (AODS) disorder. The defect in the AODS, which may lead to oxidative damage, occurs early in the course of illness and is independent of the treatment, the duration and the number of recurrent episodes.
出处 《中国校医》 2010年第5期366-368,共3页 Chinese Journal of School Doctor
关键词 双相情感障碍 氧化性应激 清蛋白类 尿酸 胆红素 Bipolar Disorder Oxidative Stress Albumins Uric Acid Bilirubin
  • 相关文献

参考文献16

  • 1杨春强.双相情感障碍的最新研究进展[J].精神医学杂志,2007,20(6):408-410. 被引量:19
  • 2Kupfer DJ. The increasing medical burden in bipolar disorder [J ]. 2005,293 (20) : 2528 - 2530.
  • 3Hoekstra R, Fekkes D, Pepplinkhuizen L, et al. Nitric oxide and neopterin in bipolar affective disorder[J]. Neuropsychobiology,2006, 54(1)..75-81.
  • 4Machado-Vieira R, Andreazza AC, Viale CI, et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects[J].Neurosci Lett,2007,421(1) :33 - 36.
  • 5Andreazza AC, Kauer-Saat' anna M, Freu BN, et al. Oxidative stress markers in bipolar disorder: a meta-analysis [ J ]. J Affect Disorder, 2008,111 (2 - 3) : 135 - 44.
  • 6姜桂兰,孔伶俐.氧化应激与精神分裂症的研究进展[J].国际精神病学杂志,2008,35(3):138-140. 被引量:12
  • 7Andreazza AC, Cassini C, Rosa AR, et al. Serum S100B and antioxidant enzymes in bipolar patients[J]. J Psychiatr Res, 2007, 41 (6) :523 - 529.
  • 8Ozcan ME, Gulec M, Ozerol E, et al. Antioxidant enzyme activities and oxidative stress in affective disorders [ J ]. Int Clin Psychopharmacol, 2004,19 ( 2 ) : 89 - 95.
  • 9Kuloglu M, Ustundag B, Atmaca M, et al. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder[J]. Cell Biochem Funct,2002,20(2) : 171 - 175.
  • 10American Psychiatric Association. Diagnostic and statistical manual of mental disorders [ R ]. 4th edition, WashingtonDC: American Psychiatric Association. 2004.

二级参考文献17

共引文献29

同被引文献15

  • 1温盛霖,程敏锋,王厚亮,岳计辉,王宏,钟志勇,郑俩荣.精神分裂症患者血清白蛋白、尿酸、胆红素和谷酰转肽酶水平的研究[J].中华临床医师杂志(电子版),2012,6(19):5922-5925. 被引量:23
  • 2Steel Z, Marnane C, Iranpour C, et al. The global prevalence of com- mon mental disorders: a systematic review and meta-analysis 1980 - 2013[ J]. Int J Epidemiol,2014,43 (2) :476 - 493.
  • 3Brown NC, Andreazza AC, Young LT. An updated recta-analysis of oxidative stress markers in bipolar disorder[J]. Psychiatry Res,2014, 218(1 -2) :61 -68.
  • 4Dean OM, van den Buuse M, Bush A[, et aL A role for SIutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice[ J]. Curr Med Chem,2009, 16 (23) :2965 - 2976.
  • 5Steckert AV, Valvassori SS, Varela liB, et al. Effects of sodium bu- tyrate on oxidative stress and behavioral changes induced by adminis- tration of D-AMPH[J]. Neurochem Int,2013,62(4) :425 -432.
  • 6Joshi YB, Pratico D. Lipid peroxidation in psychiatric illness : overview of clinical evidence[J]. Oxid Med Cell Longev,2014,2014:828702,.
  • 7de Sousa RT, Zarate CA Jr, Zanetti MV, et al. Oxidative stress in early stage Bipolar Disorder and the association with response q lithtlm[J]. J Psychiatr Res ,2014,50:36 - 41.
  • 8Suda S, Katsura K, Kanamaru T, et al, Valproic acid attenuates is- chemia-repeffusion injury in the rat brain through inhibition of oxida- tive stress and inflammation [ J ]. Eur J Pharmaco1,2013,707 ( 1 - 3 ) : 26 -31.
  • 9Rizak J, Tan H, Zhu H, et al. Chronic treatment with the mood-sta- bilizing drug lithium up-regulates nuclear factor E2-related factor 2 in rat pheochromocytoma PC 12 cells in vitro [ J ]. Neuroscience, 2014,256:223 - 229.
  • 10Khairova R, Pawar R, Salvadore G, et al. Effects of lithium on oxi- dative stress parameters in healthy subjects[ J]. Mol Med Rep,2012, 5(3) :680 -682.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部